His Excellency Ambassador Antony Stokes LVO attended a presentation at the Center for Genetic Engineering and Biotechnology (CIGB) to learn of the progress of...
The president of the business group BioCubaFarma, Eduardo Martinez, announced that by the year 2021 all Cubans will be vaccinated against COVID-19. On October...
The Center for Genetic Engineering and Biotechnology (CIGB) presented the required documentation to the regulatory authority for Drugs, Equipment and Medical Devices (CECMED) on...
Two more drugs, CIGB-258 and Itolizumab (Anti-CD6), manufactured by the Center for Genetic Engineering and Biotechnology (CIGB) have been added to Cuba’s arsenal of...
Dr. Gerardo Guillén Nieto, the Director of Biomedical Research at the Center for Genetic Engineering and Biotechnology (CIGB), of the BioCubaFarma Group, said a...
More than 45 countries have requested Cuba’s Interferon Alpha 2B Recombinant, the only drug currently available to combat COVID19 (coronavirus). The drug is manufactured...
Researchers and scientists from the BioCubaFarma group are currently developing new drugs to fight the spread of COVID-19. These new anti-viral drugs are based...
The Cuban skin cancer drug HeberFERON has demonstrated promising results in the treatment of skin cancer (basal cell carcinoma). HeberFERON, produced by Cuba’s Center...